You Just Bought CVM. We Message Board Posters Welcome You!
About Cel-Sci and their Phase III drug candidate Multikine
Lots of good details can be found on their website: Cel-Sci.com. But the best recap is their Corporate Presentation. Link below:
Zacks provided a nice recap recently as well. Link below:
Trial "should have" ended in December 2018, why the "delay"?
Delays are never good, right? Here is the thing... The trial ends when the 298th event (death) happens. But people aren't dying as fast as statistics would suggest for survival of Head and Neck cancer patients. Why? We believe its Multikine
The IDMC recently, 3/29/19, reviewed the UNBLINDED data for efficacy, safety and FUTILITY. Their recommendation: Continue the trail until the last event! Details Here
Need more proof and you're a Stats Junkie? Then head on over to the Google Sheets created by our "National Treasure" FOSCO and team from the iHub message boards. These sheets estimate that we are now past 10% of Standard Care. These sheets take into account all different survival stats for Head and Neck cancer patients at 3 and 5 yrs. Feel free to poke around...don't worry the sheets are protected and you cant mess anything up!
Straight from the CEO himself. BTW he has over 1M shares (bought more on 5/7)
On 5/16, a new interview is out:
On 5/8, Geert issued a Press Release:
Geert did an interview 5/2/19
4/11/19 Interview with Geert. Link below:
Geert recently gave some awkward dude an interview. Link below:
Musings by MellowMood from StockTwits (courtesy of MellowMood)
- Ergomed (CRO) announced in their Annual Report that they expect to finish the trial 1H19.
- Ergomed has a lot of "skin in the game" Link (They have direct access to trial data)
- CVM had to extend ERGOMED ("CRO") contract because they thought trial would be over by now. Multikine ("MK") we believe is helping patients live longer.
- During phase 2 of the trial there was a 10% complete response to tumors. Completely eradicated.
- IDMC just gave the go ahead to continue trial. Did not stop it for futility. The longer the trial goes the better the efficacy numbers.
- Recently just passed $5.00. Institutions will start to pour in. Heavily undervalued for a possible blockbuster in only head and neck cancer indication.
- Can use MK for many other cancers. So after FDA approval the long term potential for this stock can be $10B-$50B dollars. It’s not even $200M yet.
- why it’s been steadily rising the last week. It’s fair value right now is $500M MINIMUM in my opinion as other companies are worth as much with only phase 2 trials.
- Can be bought out for over a billion dollars at any moment. Happens all the time with potential blockbuster drugs.
- In 2016 the FDA removed their hold on the Phase 3 trial of MK. **According to their own guidelines, the FDA needs to see a "likelihood" of approval to remove the hold.**
$5 IS a Magic Number...Buckle Up!
We recently climbed over the "magic number" of $5.00. What does that mean?
Many firms and funds use the below $5.00 mark as a designation as a "penny stock". Most larger firms and funds will NOT let their Brokers solicit/buy a stock under $5.00. In fact, it is in many of their Bylaws not to purchase stock under $5.00.
Here is a link to some additional information:
But guess what, we are over the $5.00 mark and when I say "Giddy Up", I mean "Giddy Up!"
THIS WEBSITE SHOULD NOT BE CONSIDERED INVESTMENT ADVICE. THIS SITE WAS CREATED BY A NUT JOB WITH TOO MUCH TIME ON HIS HANDS. THIS NUT JOB HAS SHARES OF CVM AND IS LONG. THIS NUT JOB ISN'T BEING COMPENSATED FOR THIS SITE. ALL THESE OPINIONS ARE OF A NUT JOB.
SHORTS ARE SPREADING RUMORS!
Reverse Splits? Huh? That's Rich!!!!
REVERSE SPLITS is the latest SHORT tactic! Yes, we have had 3 Reverse Splits. But that was then due to low share price. Did you know a Reverse Split REQUIRES Shareholder approval? Its true. This approval request is done via a Proxy. Here is the latest Proxy from a few weeks back:
****DID YOU SEE ANY REQUEST FOR AN APPROVAL OF A REVERSE SPLIT!?***
Furthermore, why would we do a Reverse Split now that we are at $5.00? Are we at threat to be delisted? No! Here is why companies do Reverse Splits:
Cash Cash and More Cash!
This is always an issue with Biotechs. Constant financing. Dilution. Wash, Rinse, Repeat.
The last 10Q as of 3/31/19 stated they have over $13M of cash. No offering until early 2020!
Visit Cash Page for current details
The Stock Price Will Never Amount To Anything! Really?
Really? We currently have a $180M (as of 4/8/19) Market Cap and a share price over $5.00. Do some due diligence. Upon a successful read out of the Phase III data, we are talking Billions and Billions! I wont give you share price expectations, but what I will give you is recent buyouts of other bios:
- Eli Lilly bought Loxo Oncology for about $8 billion. Just $8 billion.
- https://www.fool.com/investing/2018/07/05/3-best-biotech-acquisitions-of-2018-so-far.aspx
- https://en.wikipedia.org/wiki/List_of_largest_pharmaceutical_mergers_and_acquisitions
- Google the stock BPTH. Phase 2 Biotech. Take a look what happened there in just 1 day.
Do the math! We are at $150M with about 33M shares outstanding....How does one get to a $5B-$10B. Market Cap...? The multiples are insane, but its possible!
Shorts Will Lie, Lie and Lie
Bashers Bash. See why here: https://messageboardfools.com/bashers.htm
They will say anything to make your give up your shares. Stay long!
THIS WEBSITE SHOULD NOT BE CONSIDERED INVESTMENT ADVICE. THIS SITE WAS CREATED BY A NUT JOB WITH TOO MUCH TIME ON HIS HANDS. THIS NUT JOB HAS SHARES OF CVM AND IS LONG. THIS NUT JOB ISN'T BEING COMPENSATED FOR THIS SITE. ALL THESE OPINIONS ARE OF A NUT JOB.